SENS Stock Analysis: Buy, Sell, or Hold?
SENS - Senseonics Holdings, Inc.
$7.05
-0.20 (-2.76%)
▼
5d:
-4.08%
30d:
+19.69%
90d:
+0.0%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Mar 02, 2026
26d
Get Alerted When SENS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SENS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SENS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SENS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SENS is currently trading at $7.05, which is considered fair relative to its 30-day fair value range of $6.18 to $7.46.
Technical Outlook: Technically, SENS is in a strong uptrend. Immediate support is located at $6.62, while resistance sits at $7.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.92 (+160.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SENS is in a strong uptrend. Immediate support is located at $6.62, while resistance sits at $7.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.92 (+160.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.18 -
$7.46
Company Quality Score
57/100
(HOLD)
Options IV Signal
19th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 19th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 160.9% below Wall St target ($18.92)
Fair Price Analysis
30-Day Fair Range
$6.18 -
$7.46
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.04
(14.7%)
Support & Resistance Levels
Support Level
$6.62
Resistance Level
$7.74
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.05
Wall Street Target
$18.92
(+160.9%)
Revenue Growth (YoY)
89.9%
Profit Margin
-217.6%
Last updated: February 03, 2026 9:15 AM ET
Data refreshes hourly during market hours. Next update: 10:15 AM
Data refreshes hourly during market hours. Next update: 10:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SENS showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 59 HOLD |
